Forte Biosciences (NASDAQ: FBRX)
$14.23
(-3.5%)
-$0.52
Price as of October 14, 2025, 2:34 p.m. ET
Forte Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Forte Biosciences Company Info
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
News & Analysis
Featured Article
Forte Biosciences Tops Q2 Loss Forecasts
Motley Fool Markets Team | Aug 14, 2025
Featured Article
Why Forte Biosciences Stock Is Imploding Today
The company announced dismal results from a phase 2 study of its only pipeline candidate.
Keith Speights | Sep 3, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.